BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 10623471)

  • 1. Microtubule inhibitors elicit differential effects on MAP kinase (JNK, ERK, and p38) signaling pathways in human KB-3 carcinoma cells.
    Stone AA; Chambers TC
    Exp Cell Res; 2000 Jan; 254(1):110-9. PubMed ID: 10623471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT.
    Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ
    Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of mitogen-activated protein kinases and phosphorylation of Bcl-2 by vinblastine represent persistent forms of normal fluctuations at G2-M1.
    Fan M; Du L; Stone AA; Gilbert KM; Chambers TC
    Cancer Res; 2000 Nov; 60(22):6403-7. PubMed ID: 11103805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells.
    Seidman R; Gitelman I; Sagi O; Horwitz SB; Wolfson M
    Exp Cell Res; 2001 Aug; 268(1):84-92. PubMed ID: 11461121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
    Chang ZL; Lin MQ; Wang MZ; Yao Z
    Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of mitogen-activated protein kinase pathways during Escherichia coli-induced apoptosis in U937 cells.
    Wang JH; Zhou YJ; He P; Chen BY
    Apoptosis; 2007 Feb; 12(2):375-85. PubMed ID: 17191113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells.
    Shtil AA; Mandlekar S; Yu R; Walter RJ; Hagen K; Tan TH; Roninson IB; Kong AN
    Oncogene; 1999 Jan; 18(2):377-84. PubMed ID: 9927194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.
    Singh R; Ahmed S; Malemud CJ; Goldberg VM; Haqqi TM
    J Orthop Res; 2003 Jan; 21(1):102-9. PubMed ID: 12507586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells.
    Huang Y; Sheikh MS; Fornace AJ; Holbrook NJ
    Oncogene; 1999 Jun; 18(23):3431-9. PubMed ID: 10376521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTH regulation of c-Jun terminal kinase and p38 MAPK cascades in intestinal cells from young and aged rats.
    Buzzi N; Boland R; de Boland AR
    Biogerontology; 2007 Apr; 8(2):189-99. PubMed ID: 17120084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.
    Liu W; Liang Q; Balzar S; Wenzel S; Gorska M; Alam R
    J Allergy Clin Immunol; 2008 Apr; 121(4):893-902.e2. PubMed ID: 18395552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle cell activation by low-energy laser irradiation: a role for the MAPK/ERK pathway.
    Shefer G; Oron U; Irintchev A; Wernig A; Halevy O
    J Cell Physiol; 2001 Apr; 187(1):73-80. PubMed ID: 11241351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
    Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
    Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
    Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotion of photodynamic therapy-induced apoptosis by stress kinases.
    Xue Ly; He J; Oleinick NL
    Cell Death Differ; 1999 Sep; 6(9):855-64. PubMed ID: 10510467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of multiple mitogen-activated protein kinases in pro/pre-B cells by GW7845, a peroxisome proliferator-activated receptor gamma agonist, and their contribution to GW7845-induced apoptosis.
    Schlezinger JJ; Emberley JK; Sherr DH
    Toxicol Sci; 2006 Aug; 92(2):433-44. PubMed ID: 16672323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of three mitogen-activated protein kinases on lipoprotein (a)-induced human mesangial cell proliferation.
    Song HM; Wei M; Xu K; Li XW
    Chin Med J (Engl); 2010 Jan; 123(2):216-20. PubMed ID: 20137374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy.
    Klotz LO; Fritsch C; Briviba K; Tsacmacidis N; Schliess F; Sies H
    Cancer Res; 1998 Oct; 58(19):4297-300. PubMed ID: 9766656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.